Cell Therapy Equipment
-
Manufactured by Orthocell Ltd.based in AUSTRALIA
Cell therapy aims to treat diseased or damaged tissue by local implantation or injection of healthy cells where tissue repair is needed. The use of a patient’s own cells (i.e autologous) to repair tissue damage reduces the risk of rejection or transmission of infectious diseases. ...
-
Manufactured by Kangstem Biotech Co., Ltd.based in SOUTH KOREA
FURESTEM-RA Inj. targets moderate to severe rheumatoid arthritis ...
-
Manufactured by ASC Therapeuticsbased in USA
Stem cells, including inducible pluripotent stem cells, mesenchymal stem cells (MSCs) and other primary pluripotent cells, hold the potential to treat a variety of diseases. We are currently focusing on developing an allogeneic decidua stromal cells (DSCs)-based platform to treat severe immune-mediated diseases. ...
-
Manufactured by Cellaïonbased in BELGIUM
HepaStem is Promethera’s lead cell therapy product currently in Phase 2 clinical trials for ACLF. It consists of human allogeneic liver-derived medicinal signaling cells that are obtained from healthy, ethically donated organs and expanded in the manufacturing GMP factory. HepaStem is administered as a simple peripheral intravenous ...
-
Manufactured by Tactiva Therapeuticsbased in USA
Adoptive Cell Transfer (ACT) is a form of immunotherapy that targets tumors specifically and potently by utilizing large numbers of a patient’s own immune cells to target and destroy cancer cells. Typically, starting with a few immune cells derived from the patient’s blood, billions of cancer fighting immune ...
-
Manufactured by Minaris Regenerative Medicine, LLCbased in USA
At Minaris Regenerative Medicine, we are committed to bringing together and further developing highly talented, skilled, and dedicated experts with varied backgrounds applicable to gene and cell therapy manufacturing and development. Having this team creates the potential to accelerate your progress to market and to both anticipate and ...
-
based in USA
A wholly-owned pipeline of novel cell therapy products. Neurona is developing allogeneic, off-the-shelf neural cell therapies for multiple chronic neurological disorders. The pipeline includes neuronal, glial, and gene-edited cell therapy candidates led by NRTX-1001, a first-in-class inhibitory ...
-
based in USA
Cytori is developing cell therapies that harness the unique attributes of living cells that are present in an adult human patient’s own adipose (fat) tissue, also known as Adipose-Derived Regenerative Cells ...
-
Manufactured by The Electrospinning Company Ltd.based in UNITED KINGDOM
Significant advances in recent years mean that cell therapy is becoming a clinical reality. The unique characteristics of electrospun materials, including scaleability, minimal immunogenicity, regulatory familiarity and the ability to create a custom product, mean that they are well suited for this exciting area of regenerative medicine. ...
-
Manufactured by Biocardia, Inc.based in USA
The investigational CardiAMP™ Cell Therapy is designed to be a comprehensive biotherapeutic heart failure solution, incorporating: a proprietary molecular diagnostic to characterize the potency of a patient’s own bone marrow cells and determine if they are an optimal candidate for therapy. a point of care processing ...
-
based in USA
VetStem is currently evaluating the use of stem cells for treatment in: Laminitis, Uveitis, Exercise Induced Pulmonary Hemorrhage ...
-
based in USA
Innovators in immunotherapy, stem cell therapy, and regenerative medicine will find like-minded champions at ...
-
Manufactured by Gritstone Biobased in USA
We are leveraging EDGE to define targets for T-cell receptor (TCR) directed cell therapies. These additional targets that were identified and validated by Gritstone EDGE™ enable us to partner with others or develop additional therapeutic approaches to redirect T cells onto tumors using these highly specific ...
-
Manufactured by Biocardia, Inc.based in USA
Where the CardiAMP Cell Therapy System uses a patient’s own cells, the CardiALLO system uses culture-expanded, bone marrow-derived mesenchymal stem cells from a universal donor. This allows the cells to be obtained "off the shelf" from a pharmacy, negating the need for a bone marrow aspirate for the patient ...
-
Manufactured by AGC Biologicsbased in USA
AGC Biologics develops and manufactures diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, ...
-
Manufactured by IMPACT International GmbHbased in GERMANY
Autologous cell therapies make use of the natural endogenous mechanisms for the regeneration and healing of injured tissue. The body’s response to an injury is a complex healing cascade in order to heal the wound as quickly as possible. To understand how this regeneration process works, let us take a look into the cellular ...
-
Manufactured by Protara Therapeutics, Inc.based in USA
TARA-002 is an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). TARA-002 was developed from the same master cell bank of genetically distinct group A Streptococcus pyogenes as OK-432, a broad immunopotentiator marketed as Picibanil® in ...
-
Manufactured by Kiadis Pharma NVbased in NETHERLANDS
Ushering in the Future of NK-cell Therapy: Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these ...
-
Manufactured by Bone Therapeutics SAbased in BELGIUM
ALLOB is the Company’s off-the-shelf, allogeneic cell therapy platform consisting of human allogeneic bone-forming cells derived from ex-vivo cultured bone marrow mesenchymal stromal cells (MSC) from healthy adult donors, offering numerous advantages in product quality, injectable quantity, production, logistics and cost as ...
-
Manufactured by Biosceptre International Limitedbased in UNITED KINGDOM
CAR T-cell therapy is the engineering of a patient’s T cells, a type of white blood cell. A small portion of these cells are collected, from a patient’s blood sample, and re-engineered to produce chimeric antigen receptors (CAR’s) on the cell surface. The chimeric antigen ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you